| Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence A Samoylenko, JA Hossain, D Mennerich, S Kellokumpu, JK Hiltunen, ... Antioxidants & redox signaling 19 (17), 2157-2196, 2013 | 115 | 2013 |
| EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro Oncology 18 (12), 1644-1655, 2016 | 112 | 2016 |
| The angiogenic switch leads to a metabolic shift in human glioblastoma KM Talasila, GV Røsland, HR Hagland, E Eskilsson, IH Flønes, S Fritah, ... Neuro-oncology 19 (3), 383-393, 2017 | 72 | 2017 |
| TGF-β promotes microtube formation in glioblastoma through thrombospondin 1 JV Joseph, CR Magaut, S Storevik, LH Geraldo, T Mathivet, MA Latif, ... Neuro-oncology 24 (4), 541-553, 2022 | 63 | 2022 |
| GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity DC Watson, D Bayik, S Storevik, SS Moreino, SA Sprowls, J Han, ... Nature cancer 4 (5), 648-664, 2023 | 58 | 2023 |
| Tumor-associated macrophages in gliomas—basic insights and treatment opportunities JK Andersen, H Miletic, JA Hossain Cancers 14 (5), 1319, 2022 | 54 | 2022 |
| Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects JA Hossain, A Marchini, B Fehse, R Bjerkvig, H Miletic Neuro-Oncology Advances 2 (1), vdaa013, 2020 | 41 | 2020 |
| Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma JA Hossain, MA Latif, LAR Ystaas, S Ninzima, K Riecken, A Muller, ... Neuro-oncology 21 (7), 890-900, 2019 | 34 | 2019 |
| Cancer suicide gene therapy with TK. 007 JA Hossain, K Riecken, H Miletic, B Fehse Suicide Gene Therapy: Methods and Protocols, 11-26, 2019 | 24 | 2019 |
| Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry A Kulkarni, T Ferreira, C Bretscher, A Grewenig, N El-Andaloussi, ... Nature Communications 12 (1), 3834, 2021 | 22 | 2021 |
| Lentiviral HSV‐Tk.007‐mediated suicide gene therapy is not toxic for normal brain cells JA Hossain, LR Ystaas, J Mrdalj, K Välk, K Riecken, B Fehse, R Bjerkvig, ... The Journal of Gene Medicine 18 (9), 234-243, 2016 | 17 | 2016 |
| Oncolytic H-1 parvovirus hijacks galectin-1 to enter cancer cells T Ferreira, A Kulkarni, C Bretscher, PV Nazarov, JA Hossain, LAR Ystaas, ... Viruses 14 (5), 1018, 2022 | 11 | 2022 |
| Comparing tumor cell invasion and myeloid cell composition in compatible primary and relapsing glioblastoma D Zhao, H Zhang, R Uyar, JA Hossain, H Miletic, JC Tonn, R Glass, ... Cancers 13 (14), 3636, 2021 | 10 | 2021 |
| The potentials and pitfalls of using adult stem cells in cancer treatment MK Das, TR Lunavat, H Miletic, JA Hossain Cell Biology and Translational Medicine, Volume 12: Stem Cells in …, 2021 | 3 | 2021 |
| Letter regarding “Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas” JA Hossain, H Miletic Neuro-oncology 22 (12), 1882-1883, 2020 | 2 | 2020 |
| P08. 42 Long-term treatment with Valganciclovir improves lentiviral suicide gene therapy for glioblastoma J Al Hossain, L Ystaas, KM Talasila, K Riecken, B Fehse, R Bjerkvig, ... Neuro-Oncology 19 (Suppl 3), iii63, 2017 | 2 | 2017 |
| EXTH-68. RECURRENT XENOGRAFT TUMORS UPREGULATE EGFR AFTER LENTIVIRAL VECTOR MEDIATED SUICIDE GENE THERAPY FOR GLIOBLASTOMA, BUT ARE RESISTANT TO COMBINATORIAL TREATMENT WITH … J Hossain, L Ystaas, A Latif, J Joseph, K Talasila, S Ninzima, K Riecken, ... Neuro-Oncology 19 (suppl_6), vi88-vi88, 2017 | 1 | 2017 |
| AI-10 DISTINCT EGFR SIGNALING IN GLIOBLASTOMA: WILD-TYPE EGFR PROMOTES INVASION WHILE EGFRvIII DRIVES PROTOTYPICAL SFK c-SRC ACTIVATION TO FOSTER ANGIOGENESIS E Eskilsson, G Røsland, K Talasila, R Jahedi, L Leiss, H Saed, O Keunen, ... Neuro-oncology 16 (suppl_5), v3-v3, 2014 | 1 | 2014 |
| Deciphering Human Glioblastoma Invasion Using a Developmental Mature Rat Brain Organoid Model W Zhou, E Martinez-Garcia, K Sarnow, G Kanli, P Nazarov, SG Schwab, ... | 1 | |
| IMMUNOGENIC AND IMMUNOSUPPRESSIVE ASPECTS OF HSV-TK/GCV-MEDIATED SUICIDE GENE THERAPY IN GLIOMA CELLS J Hossain, A Latif, R Chaudhuri, E Solel, L Ystaas, R Bjerkvig, H Miletic NEURO-ONCOLOGY 25, 2023 | | 2023 |
Boris FehseUniversity Medical Center Hamburg-Eppendorf在 uke.uni-hamburg.de 的电子邮件经过验证
